Sharma S, Hashmi MF, Bhattacharya PT. Hypotension. In: StatPearls. StatPearls Publishing; 2022. http://www.ncbi.nlm.nih.gov/books/NBK499961/. Accessed August 28, 2022.
McClelland DB. ABC of transfusion. Human albumin solutions BMJ. 1990;300(6716):35–7.
Scholtz M. Hippocrates’ aphorisms Calif West Med. 1940;53(6):272.
Peters Jr, T. All about albumin: biochemistry, genetics, and medical applications. Academic Press; 1995.
Dekkers F. Exercitationes Practicae circa Medendi Methodum. Boutensteyn and Luchtmans; 1694.
Course of lectures on the physiology and pathology of the blood, and the other animal fluids. The Lancet. 1840;34(872):257–264.
Moman RN, Gupta N, Varacallo M. Physiology, albumin. In: StatPearls. StatPearls Publishing; 2022. http://www.ncbi.nlm.nih.gov/books/NBK459198/. Accessed September 11, 2022.
Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–7.
Article CAS PubMed Google Scholar
Hahn RG. Colloid fluids. In: Hahn RG, editor. Clinical fluid therapy in the perioperative setting. 2nd ed. Cambridge University Press; 2016. p. 10–9.
Guyton A, Hall J. Textbook of medical physiology. 10th ed. Co: W.B. Saunders; 2000.
MI Griffel, Kaufman B. Pharmacology of colloids and crystalloids. Crit Care Clin. 8:235–254.
Khawar H, Kelley W, Stevens JB, Guzman N. Fresh frozen plasma (FFP). In: StatPearls. StatPearls Publishing; 2022. http://www.ncbi.nlm.nih.gov/books/NBK513347/. Accessed September 10, 2022.
Baron JF. Crystalloids or colloids for the treatment of hypovolemia? Transfus Altern Transfus Med. 1999;1(4):12–26.
Nearman HS, Herman ML. Toxic effects of colloids in the intensive care unit. Crit Care Clin. 1991;7(3):713–23.
Article CAS PubMed Google Scholar
Drumi W, Polzleitner D, Laggner A, et al. Dextran-40, acutre renal failure, and elevated plasma oncotic pressure. N Engl J Med. 1988;318:252–4.
Richter AW. Immune complex anaphylaxis induced by dextran and its elimination by hapten inhibition. In: Ring J, Burg G, editors. New trends in allergy II. Springer; 1986. p. 272–83.
de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001;29(6):1261–7.
Brunkkorst FM, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.
Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367(2):124–134.
Magder S, Potter BJ, DeVarennes B, Doucette S, Fergusson D. Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids. Crit Care Med. 2010;38(11):2117–24.
Muller L, Lefrant JY. Metabolic effects of plasma expanders. Transfus Altern Transfus Med. 2010;11(s3):10–21.
Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Réanimation. 1994;13(3):301–310.
Evans PA, Glenn JR, Heptinstall S, Madira W. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth. 1998;81(2):198–202.
Article CAS PubMed Google Scholar
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063.
Rochwerg B, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med. 2014;161:347–55.
Tseng CH, Chen TT, Wu MY, Chan MC, Shih MC, Tu YK. Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses. Crit Care. 2020;24(1):693.
Article PubMed PubMed Central Google Scholar
Martin GS, Bassett P. Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: a systematic review and meta-analysis. J Crit Care. 2019;50:144–154.
Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259–65.
Matejtschuk P, Dash CH, Gascoigne EW. Production of human albumin solution: a continually developing colloid. Br J Anaesth. 2000;85(6):887–95.
Article CAS PubMed Google Scholar
• Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317(7153):235–240. Review of literature that suggested that albumin administration in critically ill patients was non-superior to other fluids and that albumin may confer increased morbidity and mortality.
McClelland B. Albumin: don’t confuse us with the facts. BMJ. 1998;317(7162):829–30.
Article CAS PubMed PubMed Central Google Scholar
Roberts I, Edwards P, McLelland B. Use of human albumin in the UK fell substantially when systematic review was published. BMJ. 1999;318(7192):1214.
Article CAS PubMed PubMed Central Google Scholar
Petros A, Schindler M, Pierce C, Jacobe S, Mok Q. Human albumin administration in critically ill patients. BMJ. 1998;317(7162):882.
Article CAS PubMed PubMed Central Google Scholar
Watts J. Fluid resuscitation with colloid or crystalloid solutions. BMJ. 1998;317(7153):277.
Article CAS PubMed PubMed Central Google Scholar
Fergal, D. Letter to doctors. Washington, DC: Food and Drug Administration, Center for Biologics Evaluation and Research https://scholar.google.com/scholar_lookup?title=Letter+to+doctors.&author=D+Fergal&publication_year=1998. Accessed 22 Sept 2022.
Horsey PJ. The Cochrane 1998 albumin review – not all it was cracked up to be. Eur J Anaesthesiol. 2002;19(10):701.
Wilkes MM, Navickis RJ. Patient survival after human albumin administration. Ann Intern Med. 2001;135(3):149–64.
Article CAS PubMed Google Scholar
•• The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–2256. First major clinical trial that compared albumin vs saline for fluid resuscitation in ICU patients. Demonstrated no increased mortality with albumin, and even some improved outcomes compared to saline.
The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357:874–84.
•• Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412–1421. Second major clinical trial that demonstrated benefit in giving albumin with crystalloid fluids in critically ill patients with severe sepsis and septic shock.
Vincent JL, De Backer D, Wiedermann CJ. Fluid management in sepsis: the potential beneficial effects of albumin. J Crit Care. 2016;35:161–7.
Comments (0)